GenericAll countries · Checked
Rybelsus Generic Name: Is There a Generic Rybelsus?
The generic name of Rybelsus is semaglutide tablets. As of November 20, 2026, generic oral semaglutide has been on sale in India since March 21, 2026, and no generic Rybelsus is confirmed in the US.
Is there a generic Rybelsus?
In India, yes. In the US, not yet. The generic name is semaglutide.
Generic nameSemaglutide tablets
IndiaSembolic and Semalix, since March 21, 2026
USNo generic confirmed, ingredient patent to 2032
The maker of Rybelsus is Novo Nordisk. Based on the US product label, the Novo Nordisk annual report and Torrent's announcement.
In the US, you still pay the brand price today.
See what Rybelsus costs in the USIn the US? Check the Rybelsus coupon and savings card too.
Generic nameIndiaUSCanadaWeight lossDosesSide effectsPriceWhenFAQ
Rybelsus generic name
Rybelsus is a brand name. Semaglutide is the medicine inside it.
Rybelsus is a semaglutide tablet taken once a day. The same ingredient is sold as an injection under the names Ozempic and Wegovy.
In the US, Rybelsus is approved for two uses in adults with type 2 diabetes: improving blood sugar control, and lowering the risk of heart attack and stroke in people at high risk.
What the tablet does and who takes it is covered in Rybelsus (semaglutide tablets).
Generic Rybelsus in India
In India, generic oral semaglutide first went on sale on March 21, 2026.
Generic oral semaglutide in India
CompanyTorrent Pharma
BrandsSembolic and Semalix, oral and injectable
Launch dateMarch 21, 2026
Torrent says it is the first company in India to launch generic oral semaglutide.
The injectable from the same company starts at INR 3,999 a month. The announcement gives no price for the tablet.
The brand names differ, but the ingredient is semaglutide. Injection prices there are in semaglutide price in India.
Generic Rybelsus in the US
No generic Rybelsus is confirmed in the US. The patent on the ingredient has not run out.
Rybelsus ingredient patent expiry, as listed by Novo Nordisk
United States2032
Europe2031
Japan2031
China2026
The European year is based on Germany. These years cover the ingredient patent only, and Novo Nordisk may hold other patents on making and formulating the tablet.
An expired patent does not put a generic on the shelf by itself. A regulator still has to approve each product.
Generic for Rybelsus in Canada
Health Canada announced a generic semaglutide on April 28, 2026, but it is an injection, not a tablet.
The product from Dr. Reddy's is a generic version of Ozempic, a once-weekly treatment for adults with type 2 diabetes.
So that announcement does not describe a generic tablet. The injection side is in generic Ozempic, and the list by country is in generic semaglutide.
Rybelsus generic for weight loss
Rybelsus has no weight loss use in its US label. The weight loss tablet is a different Novo Nordisk brand, the Wegovy pill.
The Wegovy pill is also a semaglutide tablet, with strengths of 1.5 mg, 4 mg, 9 mg and 25 mg in the US label. It is its own brand and not a generic of Rybelsus.
No generic Wegovy pill is confirmed either. Doses and how it compares with the injection are in Wegovy pill, and the injection side is in Wegovy generic name.
Rybelsus doses a generic would follow
A generic is approved as the same as the brand, so the benchmark is the Rybelsus schedule used today.
13 mgDays 1 to 30The starting dose. It is not effective for blood sugar control.
27 mgDays 31 to 60The first maintenance dose.
314 mgFrom day 61Used only if more blood sugar control is needed.
Rybelsus comes in two formulations. R1 has 3 mg, 7 mg and 14 mg tablets, and R2 has 1.5 mg, 4 mg and 9 mg tablets. The two cannot be swapped milligram for milligram.
Take the tablet on an empty stomach in the morning with up to 4 ounces of plain water, then wait 30 minutes before food, drinks or other medicines. A missed dose is skipped, and the next dose is taken the following day.
The full schedule is in Rybelsus 3 mg, 7 mg and 14 mg.
Rybelsus side effects a generic would share
The same ingredient brings the same common side effects. In the US label's diabetes trials, nausea was the most common.
Common side effects in trials: placebo, 7 mg, 14 mg
Nausea6%, 11%, 20%
Abdominal pain4%, 10%, 11%
Diarrhea4%, 9%, 10%
Vomiting, decreased appetite and constipation also reached 5% or more. Nausea, vomiting and diarrhea are most common when you first start.
Generic Rybelsus price
There is no US price for a generic Rybelsus, because there is no product.
What the brand costs is in Rybelsus cost in the US, and the manufacturer offer is in Rybelsus coupon.
If you already take Rybelsus, keep taking it as prescribed. Waiting for a generic is not a reason to change your dose or skip days.
When will a generic Rybelsus come to the US?
No date is set. Novo Nordisk lists the US ingredient patent as running to 2032.
This page is updated when a generic Rybelsus is approved in the US.
The wider picture is in generic GLP-1 drugs, and the tirzepatide side is in generic Mounjaro.
Rybelsus generic FAQ
What is the generic name for Rybelsus?
Semaglutide. The tablet is called semaglutide tablets, and Ozempic and Wegovy contain the same ingredient.
Is there a generic Rybelsus in the US?
No. None is confirmed, and the US ingredient patent runs to 2032.
Which country has generic oral semaglutide?
India. Torrent launched Sembolic and Semalix on March 21, 2026.
Is generic Ozempic the same as generic Rybelsus?
No. The ingredient is the same, but generic Ozempic is an injection and Rybelsus is a tablet.
Is the Wegovy pill a generic Rybelsus?
No. The Wegovy pill is a separate Novo Nordisk brand for weight loss.
Keep reading
Rybelsus coupon and savings card
Rybelsus (semaglutide tablets)
This page follows the US product label, the Novo Nordisk annual report and regulator and company announcements, and is updated when they change. See how we check our pages.
Update log
: First published.
Sources
Rybelsus US prescribing information (FDA).
Wegovy US prescribing information (FDA), injection and tablets.
Commercial execution, patent expiry table (Novo Nordisk Annual Report 2025).
Torrent Pharma launches oral and injectable formulations of Semaglutide (stock exchange announcement, March 21, 2026).
Canada becomes the first G7 country to approve a generic version of semaglutide (Health Canada).
GLP1 Note is an independent information site. Which product you take is decided with your prescriber.